October 22, 2020 Clinical Research/Diagn. Life Science Tools

Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics

SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced a research collaboration focused on the investigation of clinically relevant molecular targets for use in... Read more

October 22, 2020 Acad, Gov/Utilities M&A, Partnerships Microscopy

St. Luke’s University Health Network Selects GE Healthcare for $11 Million Ultrasound Purchase to Create System-wide Efficiencies

(CHICAGO – October 22, 2020) GE Healthcare today announced its largest ever ultrasound deal in the United States – an $11 million order by St. Luke’s University Health Network to install GE Healthcare ultrasound technology and IT workflow solutions system-wide. GE Healthcare will continue upgrades over the next four years to maintain latest technology for... Read more

October 22, 2020 Lab Top-10 Licensing, IP, and Legal PAI Top-10 PR/Corporate

BD Announces Executive Leadership Appointments

FRANKLIN LAKES, N.J., Oct. 22, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Patrick Kaltenbach as executive vice president and chief technology officer, and the promotion of Dave Hickey to executive vice president and president, Life Sciences segment, both effective January 1, 2021.... Read more

October 22, 2020 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

Danaher Reports Third Quarter 2020 Results

WASHINGTON, Oct. 22, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended October 2, 2020. All results in this release reflect only continuing operations unless otherwise noted. For the third quarter 2020, net earnings were $883.5 million, or $1.16 per diluted common share which represents a 38.0% year-over-year... Read more

October 22, 2020 Bio/Pharma/CRO M&A, Partnerships

Roche announces collaboration with Atea Pharmaceuticals to develop a potential oral treatment for COVID-19 patients

Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials AT-527 has the potential to be the first novel oral antiviral to treat COVID-19 patients outside the hospital setting as well as in the hospital and may also be used in post-exposure prophylactic settings Oral,... Read more

October 21, 2020 Lab Top-10 Liq. Handling & Robotics Microscopy Product Launch

Bruker Introduces Vutara™ VXL Best-in-Class Super-Resolution Microscope and Spatial Biology Analysis Capabilities

Accessible 3D Single-Molecule Localization Microscopy for Studying Subcellular Organelles and Spatial Multiomics MADISON, Wisc.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the release of the Vutara VXL Super-Resolution Fluorescence Microscopefor nanoscale biological imaging. The new system opens an affordable and easy-to-use path for both core facilities and individual investigators to enter the world of super-resolution... Read more

October 20, 2020 Lab Top-10

PerkinElmer Immunoassay Helps NIH NCATS Team Identify Therapeutic Compounds Capable of Disrupting the SARS-CoV-2 Spike Protein/ACE2 Interaction

Findings shared on open data portal to help in global pursuit of drug repurposing candidates for COVID-19 WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 20, 2020– PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that a research team at the National Center for Advancing Translational Sciences (NCATS), an arm of the National... Read more